EPISODE · Jun 5, 2017 · 11 MIN
June 2017: Turning the tide of high-dose inhaled corticosteroids
from DTB Podcast · host BMJ Group
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the use of high-dose inhaled corticosteroids in asthma and COPD. The editors also highlight some of the challenges associated with the management of superficial venous thrombosis of the leg and discuss the use of carbohydrate deficient transferrin as a biomarker for the assessment of chronic alcohol use. Read more about the DTB's June 2017 issue: http://dtb.bmj.com/content/55/6#DTBSelect. Editorial: http://dtb.bmj.com/content/55/6/61. Related articles: http://dtb.bmj.com/content/55/6/66 and http://dtb.bmj.com/content/55/6/69.
What this episode covers
In this month’s podcast, James Cave (DTB Editor-in-Chief) and David Phizackerley (DTB Deputy Editor) discuss the use of high-dose inhaled corticosteroids in asthma and COPD. The editors also highlight some of the challenges associated with the management of superficial venous thrombosis of the leg and discuss the use of carbohydrate deficient transferrin as a biomarker for the assessment of chronic alcohol use. Read more about the DTB's June 2017 issue: http://dtb.bmj.com/content/55/6#DTBSelect. Editorial: http://dtb.bmj.com/content/55/6/61. Related articles: http://dtb.bmj.com/content/55/6/66 and http://dtb.bmj.com/content/55/6/69.
NOW PLAYING
June 2017: Turning the tide of high-dose inhaled corticosteroids
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m